CD4 and neoplasm: The tumors with NEAT1 knockdown M109 cell harvested from mice had intratumoral elevation in CD45+ CD3+ T cells (Figures 3D,E) and CD4– CD8+ T cells (Figures 3F,G) compared to tumor from control mice.